Semaglutide monitoring: what should you track on Wegovy?

What does 'monitoring on semaglutide' actually mean?

A common misconception is that Wegovy comes with a strict testing schedule, monthly blood draws, mandatory clinic check-ins, the works. The reality is quieter than that. The NHS semaglutide guidance and the medicine's licensed use don't prescribe a fixed timetable of laboratory tests for most adults using it for weight management. What monitoring looks like is more personalised than a checklist.

Before starting, a prescriber will typically want a reasonable picture of your baseline: your weight, BMI, blood pressure, and whether you have conditions such as type 2 diabetes, high cholesterol, or kidney disease that change what needs watching. At nume, every consultation is read by a GPhC-registered Independent Prescriber who reviews that baseline personally, software doesn't make those calls. Then, as treatment continues, the questions shift. Is your weight moving in the right direction? Are side effects manageable? Does the dose need adjusting?

For most people without complex medical histories, routine blood tests aren't a weekly or even monthly requirement. For others (those with diabetes, for example, or a history of kidney problems) more active monitoring of glucose or kidney markers makes clinical sense. The prescriber decides what's appropriate for you specifically, and that picture can change as your health changes on treatment. If you want a clearer idea of what a structured blood panel might cover, our semaglutide monitoring panel page explains that in more detail.

Which health markers are most relevant when taking Wegovy?

Weight and BMI are the obvious starting points, they're what treatment is aimed at, and they're the most straightforward markers to track over time. But they're not the only ones worth thinking about.

Blood pressure often improves alongside weight loss, so if yours was elevated at baseline it's worth reviewing periodically. Blood glucose is particularly relevant if you have type 2 diabetes or prediabetes: semaglutide can lower glucose levels, which means diabetes medication doses may need adjusting as treatment progresses, your GP or diabetes team should be looped in. Kidney function (eGFR and creatinine) can be affected by dehydration, which matters because GI side effects like nausea and vomiting in the early weeks can reduce fluid intake. Liver enzymes are occasionally reviewed in people with existing liver conditions.

Heart rate is another marker the NICE appraisal of Wegovy (TA875) notes in the context of treatment: a modest increase in resting heart rate has been observed in some people on semaglutide, worth flagging if you notice palpitations. Thyroid function isn't routinely monitored for most people, but anyone with a personal or family history of medullary thyroid carcinoma should not take semaglutide at all, that's a prescribing contraindication, not a monitoring question.

Cholesterol levels often improve with meaningful weight loss, so a lipid panel at some point through treatment can give a useful picture of overall cardiovascular risk. None of these are automatically required for everyone, they're the markers a thoughtful prescriber keeps in mind when deciding what to check and when.

What side effects should you watch for between appointments?

Wegovy lab monitoring is one piece of the picture. The other piece is knowing what to notice at home. Most side effects with semaglutide are gastrointestinal: nausea, loose stools, constipation, reflux, and burping are the common ones. They tend to be most noticeable in the first couple of weeks of a new dose and usually ease as your body adjusts. Staying well hydrated and eating smaller portions helps a lot. If you're new to the treatment, it's also worth reading up on how to store Wegovy correctly, since keeping pens at the right temperature helps ensure the medicine works as intended.

Some signs need prompt attention rather than waiting for your next review. In January 2026 the MHRA issued a Drug Safety Update for GLP-1 medicines, specifically highlighting acute pancreatitis as an infrequent but potentially serious risk. The symptom to know: severe, persistent abdominal pain that reaches through to the back, sometimes with vomiting. That's a reason to contact a GP or go to A&E the same day, not to manage at home. Gallbladder problems are separately associated with rapid weight loss in general and can sometimes occur on GLP-1 treatment, upper-right abdominal pain after eating is the pattern to watch.

Signs of a serious allergic reaction (swelling of the face, throat, difficulty breathing) or significant dehydration from persistent vomiting or diarrhoea also warrant same-day medical help. If anything is uncertain, suspected side effects can be reported through the MHRA's Yellow Card scheme, a useful resource our prescribers actively encourage patients to use. The Wegovy overview page covers the side effect profile in broader context if you'd like the full picture alongside how the treatment works.

How does ongoing monitoring fit with the private route through nume?

Choosing a private route through a regulated online pharmacy doesn't mean less oversight, it means oversight built into the service rather than attached to a GP appointment you might wait weeks for. Every repeat order at nume is clinically re-reviewed before it's approved. That's not a formality; it's a prescriber actively looking at whether the dose still makes sense, whether anything has changed, and whether treatment should continue. There's no auto-renewal, no subscription that rolls forward invisibly.

We also notify your GP in line with GPhC guidance, so your wider health record reflects the fact that you're on treatment. For questions about cost alongside the clinical side, our Wegovy pricing page lays out what's included in a single transparent price. And if you want to understand the full semaglutide journey, our guide to semaglutide takes you from what the medicine is through to what the evidence shows, and is a good place to spend ten minutes. When you're ready to speak to a prescriber about your own health picture, a free consultation is a straightforward next step.